Cargando…
Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort
SIMPLE SUMMARY: This study explored the characteristics, treatment, and survival outcomes of patients with pregnancy-associated breast cancer (PABC) in Korea. All patients of this study received standard treatments according to the National Comprehensive Cancer Network guideline. Compared to the non...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564289/ https://www.ncbi.nlm.nih.gov/pubmed/36230762 http://dx.doi.org/10.3390/cancers14194839 |
_version_ | 1784808604799336448 |
---|---|
author | Jo, Hyunji Park, Seri Kim, Hye Ryeon Kim, Hongsik Hong, Joohyun Lee, Jeong Eon Yu, Jonghan Chae, Byung Joo Lee, Se Kyung Ryu, Jai Min Oh, Soo-young Choi, Suk Joo Kim, Ji-Yeon Ahn, Jin Seok Im, Young-Hyuck Nam, Eun Mi Nam, Seok Jin Park, Yeon Hee |
author_facet | Jo, Hyunji Park, Seri Kim, Hye Ryeon Kim, Hongsik Hong, Joohyun Lee, Jeong Eon Yu, Jonghan Chae, Byung Joo Lee, Se Kyung Ryu, Jai Min Oh, Soo-young Choi, Suk Joo Kim, Ji-Yeon Ahn, Jin Seok Im, Young-Hyuck Nam, Eun Mi Nam, Seok Jin Park, Yeon Hee |
author_sort | Jo, Hyunji |
collection | PubMed |
description | SIMPLE SUMMARY: This study explored the characteristics, treatment, and survival outcomes of patients with pregnancy-associated breast cancer (PABC) in Korea. All patients of this study received standard treatments according to the National Comprehensive Cancer Network guideline. Compared to the non-PABC group, the PABC group had a lower percentage of hormone receptor positivity, increased HER2 overexpression, and higher Ki-67 levels. No maternal complications were observed in patients with PABC. In addition, the 5-year disease-free survival and overall survival rates were significantly poorer in the PABC group than in the non-PABC group. After adjusting for tumor characteristics, PABC was still associated with poor prognosis. This is the first report of the PABC population from a prospective cohort. Exploration to elucidate biologic relevance will follow. ABSTRACT: Background: Given that peak age of breast cancer (BC) is younger in Asians than in Western populations, relatively higher prevalence of pregnancy-associated breast cancer (PABC) has been reported. This study aimed to analyze the characteristics and clinical outcomes of PABC in Korea. Methods: We defined PABC as BC diagnosed during pregnancy or in the first postpartum year. We compared the clinicopathological characteristics and BC outcomes between patients with PABC and non-PABC patients in the prospective YBC cohort from Samsung Medical Center. Results: In total, 1492 patients were initially enrolled, and 1364 patients were included, of which 93 had PABC (6.8%). The median age of patients with PABC was 34 years. Hormone receptor expression was lower (64.6% vs 74.6%) and frequency of HER2 overexpression was higher (26.9% vs 17.6%) in patients with PABC than in non-PABC patients. The 5-year overall survival (OS) rates were 83.2% and 93.4% in patients with PABC and non-PABC patients, respectively (p < 0.001). The 5-year disease-free survival (DFS) rates were 72.2% and 83.8% in PABC and non-PABC patients. Conclusion: Compared to non-PABC patients, patients with PABC had poorer OS and DFS in this prospective cohort. Exploratory biomarker analysis for PABC is warranted. |
format | Online Article Text |
id | pubmed-9564289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95642892022-10-15 Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort Jo, Hyunji Park, Seri Kim, Hye Ryeon Kim, Hongsik Hong, Joohyun Lee, Jeong Eon Yu, Jonghan Chae, Byung Joo Lee, Se Kyung Ryu, Jai Min Oh, Soo-young Choi, Suk Joo Kim, Ji-Yeon Ahn, Jin Seok Im, Young-Hyuck Nam, Eun Mi Nam, Seok Jin Park, Yeon Hee Cancers (Basel) Article SIMPLE SUMMARY: This study explored the characteristics, treatment, and survival outcomes of patients with pregnancy-associated breast cancer (PABC) in Korea. All patients of this study received standard treatments according to the National Comprehensive Cancer Network guideline. Compared to the non-PABC group, the PABC group had a lower percentage of hormone receptor positivity, increased HER2 overexpression, and higher Ki-67 levels. No maternal complications were observed in patients with PABC. In addition, the 5-year disease-free survival and overall survival rates were significantly poorer in the PABC group than in the non-PABC group. After adjusting for tumor characteristics, PABC was still associated with poor prognosis. This is the first report of the PABC population from a prospective cohort. Exploration to elucidate biologic relevance will follow. ABSTRACT: Background: Given that peak age of breast cancer (BC) is younger in Asians than in Western populations, relatively higher prevalence of pregnancy-associated breast cancer (PABC) has been reported. This study aimed to analyze the characteristics and clinical outcomes of PABC in Korea. Methods: We defined PABC as BC diagnosed during pregnancy or in the first postpartum year. We compared the clinicopathological characteristics and BC outcomes between patients with PABC and non-PABC patients in the prospective YBC cohort from Samsung Medical Center. Results: In total, 1492 patients were initially enrolled, and 1364 patients were included, of which 93 had PABC (6.8%). The median age of patients with PABC was 34 years. Hormone receptor expression was lower (64.6% vs 74.6%) and frequency of HER2 overexpression was higher (26.9% vs 17.6%) in patients with PABC than in non-PABC patients. The 5-year overall survival (OS) rates were 83.2% and 93.4% in patients with PABC and non-PABC patients, respectively (p < 0.001). The 5-year disease-free survival (DFS) rates were 72.2% and 83.8% in PABC and non-PABC patients. Conclusion: Compared to non-PABC patients, patients with PABC had poorer OS and DFS in this prospective cohort. Exploratory biomarker analysis for PABC is warranted. MDPI 2022-10-04 /pmc/articles/PMC9564289/ /pubmed/36230762 http://dx.doi.org/10.3390/cancers14194839 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jo, Hyunji Park, Seri Kim, Hye Ryeon Kim, Hongsik Hong, Joohyun Lee, Jeong Eon Yu, Jonghan Chae, Byung Joo Lee, Se Kyung Ryu, Jai Min Oh, Soo-young Choi, Suk Joo Kim, Ji-Yeon Ahn, Jin Seok Im, Young-Hyuck Nam, Eun Mi Nam, Seok Jin Park, Yeon Hee Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort |
title | Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort |
title_full | Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort |
title_fullStr | Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort |
title_full_unstemmed | Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort |
title_short | Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort |
title_sort | long-term breast cancer outcomes of pregnancy-associated breast cancer (pabc) in a prospective cohort |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564289/ https://www.ncbi.nlm.nih.gov/pubmed/36230762 http://dx.doi.org/10.3390/cancers14194839 |
work_keys_str_mv | AT johyunji longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT parkseri longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT kimhyeryeon longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT kimhongsik longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT hongjoohyun longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT leejeongeon longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT yujonghan longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT chaebyungjoo longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT leesekyung longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT ryujaimin longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT ohsooyoung longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT choisukjoo longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT kimjiyeon longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT ahnjinseok longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT imyounghyuck longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT nameunmi longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT namseokjin longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort AT parkyeonhee longtermbreastcanceroutcomesofpregnancyassociatedbreastcancerpabcinaprospectivecohort |